ENTITY
WuXi AppTec

WuXi AppTec (603259 CH)

315
Analysis
Health CareChina
WuXi AppTec Co., Ltd. manufactures medical products. The Company produces biological agents, antibodies, biological diagnostic reagents, and other products. WuXi AppTec also provides biological analysis, technical study, and other services.
more
bullishWuXi AppTec
01 May 2025 20:46Broker

WuXi AppTec (603259 CH) - To Navigate Macro Uncertainties with a Good Start in 1Q25

WuXi AppTec reported impressive 1Q25 financial results. Revenue increased by 21.0% YoY to RMB9.65bn, with revenue from continuing operations rising...

Logo
178 Views
Share
bullishWuXi AppTec
29 Apr 2025 21:48

WuXi AppTec (2359 HK): In-Line 2024 Performance; Announces Dividend and A Share Buyback Plan

1Q25 resumes double-digit growth, with revenue growing 21% YoY and net profit increasing 40% YoY. Growth was driven by Wuxi Chemistry segment. U.S....

Logo
485 Views
Share
bullishWuXi AppTec
06 Apr 2025 09:18

China Healthcare Weekly (Apr.6) - SASAC to Encourage SOE M&A, WuXi AppTec Disposed XDC Shares Again

​China innovative drug industry will see big financial gains through licensing cooperation. The SASAC released new policy to encourage SOE M&A.WuXi...

Logo
452 Views
Share
11 Jul 2025 13:15

Anthem Biosciences IPO - D&M Vertical Continues to Drive CRDMO Business

Anthem Biosciences is looking to raise about US$397m in its India IPO. In this note, we will talk about the RHP updates.

Logo
286 Views
Share
bullishWuXi AppTec
20 Mar 2025 08:55

WuXi AppTec (2359.HK/603259.CH) - The Concerns Behind the 2024 Performance Rebound and 2025 Outlook

​WuXi AppTec 2024 results showed recovery, but challenges in "R" business raise concerns for 2025 growth.Geopolitical/recession risk cloud long...

Logo
526 Views
Share
x